# Global Blood Therapeutics, Inc. — Form D

Global Blood Therapeutics, Inc. of SOUTH SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2015-01-05. The offering totals $48.0M, of which $48.0M was reported sold. Industry: Other.

## Offering

- Filed: 2015-01-05
- Form: D
- Accession: 0001629137-15-000001
- Industry: Other
- Exemptions: 06b
- Total offering: $48.0M
- Amount sold: $48.0M
- Investors: 13
- Date of first sale: 2014-12-22
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-231431

## Issuer

- Name: Global Blood Therapeutics, Inc.
- CIK: 0001629137
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2011
- Address: 400 EAST JAMIE COURT, SUITE 101, SOUTH SAN FRANCISCO, CA, 94080
- Phone: 650-741-7700

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Charles W Homcy, M.D. | Director | South San Francisco, CA |
| Ted W Love | Director | Cranbury, NJ |
| Kevin W Starr | Director | South San Francisco, CA |
| Ted W Love | Executive Officer | Cranbury, NJ |
| John W Schembri | Executive Officer | South San Francisco, CA |

## More

- [CIK 1629137 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1629137&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001629137-15-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.